Lepu Medical Technology (Beijing) Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Lepu Medical Technology (Beijing) Co., Ltd. carries a market capitalization of 23.65B, placing it among publicly traded companies globally. Its enterprise value stands at 29.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 23.65B |
| Enterprise Value | 29.13B |
Share Statistics
Lepu Medical Technology (Beijing) Co., Ltd. currently has 1.88B shares outstanding.
| Shares Outstanding | 1.88B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Lepu Medical Technology (Beijing) Co., Ltd. trades at a trailing price-to-earnings ratio of 105.59. The price-to-sales ratio is 4.17, and the price-to-book ratio stands at 2.16.
| PE Ratio | 105.59 |
| PS Ratio | 4.17 |
| PB Ratio | 2.16 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | 43.09 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Lepu Medical Technology (Beijing) Co., Ltd. trades at an EV/EBITDA multiple of 36.15 and an EV/FCF ratio of 39.62. The EV/Sales ratio of 4.78 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 36.15 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.78 |
| EV / EBITDA | 36.15 |
| EV / EBIT | 36.15 |
| EV / FCF | 39.62 |
Financial Position
Lepu Medical Technology (Beijing) Co., Ltd. maintains a current ratio of 1.79, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 34.04, indicating elevated leverage, while an interest coverage ratio of 4.42 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.79 |
| Quick Ratio | 0.74 |
| Debt / Equity | 34.04 |
| Debt / EBITDA | 7.35 |
| Interest Coverage | 4.42 |
Financial Efficiency
Lepu Medical Technology (Beijing) Co., Ltd. posts a return on equity of 2.01 and a return on invested capital of 2.75.
| Return on Equity (ROE) | 2.01 |
| Return on Assets (ROA) | 0.95 |
| Return on Invested Capital (ROIC) | 2.75 |
| Return on Capital Employed (ROCE) | 2.16 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.11 |
Taxes
Over the trailing twelve months, Lepu Medical Technology (Beijing) Co., Ltd. has paid 52.23M in income taxes, reflecting an effective tax rate of 20.17.
| Income Tax | 52.23M |
| Effective Tax Rate | 20.17 |
Stock Price Statistics
Lepu Medical Technology (Beijing) Co., Ltd.'s stock has declined approximately -16.85029% over the past 52 weeks. The 50-day moving average sits at 12.95, while the 200-day moving average is 16.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.85029% |
| 50-Day Moving Average | 12.95 |
| 200-Day Moving Average | 16.11 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Lepu Medical Technology (Beijing) Co., Ltd. generated 6.09B in revenue and converted that into 240.62M in net income, yielding earnings per share of 0.11. EBITDA reached 805.71M, while operating income came in at 805.71M.
| Revenue | 6.09B |
| Gross Profit | 3.70B |
| Operating Income | 805.71M |
| Pretax Income | 258.88M |
| Net Income | 240.62M |
| EBITDA | 805.71M |
| EBIT | 805.71M |
| Earnings Per Share (EPS) | 0.11 |
Balance Sheet
Lepu Medical Technology (Beijing) Co., Ltd. holds 3.80B in cash and equivalents against 5.92B in total debt, resulting in a net debt position of -1.00B. Total book value stands at 11.78B, with working capital of 4.08B providing operational flexibility.
| Cash & Cash Equivalents | 3.80B |
| Total Debt | 5.92B |
| Net Debt | -1.00B |
| Equity (Book Value) | 11.78B |
| Book Value Per Share | 6.39 |
| Working Capital | 4.08B |
Cash Flow
After subtracting -589.63M in capital expenditures, free cash flow totaled -589.63M - equivalent to -0.32 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -589.63M |
| Free Cash Flow | -589.63M |
| FCF Per Share | -0.32 |
Margins
Lepu Medical Technology (Beijing) Co., Ltd. operates with a gross margin of 60.85, reflecting its pricing power and cost economics. The operating margin of 13.23 and net profit margin of 3.95 provide insight into operational efficiency.
| Gross Margin | 60.85 |
| Operating Margin | 13.23 |
| Pretax Margin | 4.25 |
| Profit Margin | 3.95 |
| EBITDA Margin | 13.23 |
Dividends & Yields
The company's payout ratio of 371.57 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.35 |
| Dividend Yield | N/A |
| Payout Ratio | 371.57 |
| Shareholder Yield | 2.35 |
| FCF Yield | 2.32 |
Stock Splits
Lepu Medical Technology (Beijing) Co., Ltd.'s most recent stock split took place on June 23, 2016 with a 1:2 split ratio.
| Last Split Date | 6/23/2016 |
| Split Ratio | 1:2 |
Scores
Lepu Medical Technology (Beijing) Co., Ltd. posts an Altman Z-Score of 3.39, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.39 |